These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11356996)

  • 21. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The international normalized ratio according to Owren in liver disease: interlaboratory assessment and determination of international sensitivity index.
    Magnusson M; Sten-Linder M; Bergquist A; Rajani R; Kechagias S; Fischler B; Németh A; Lindahl TL
    Thromb Res; 2013 Sep; 132(3):346-51. PubMed ID: 23993902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. European Concerted Action on Anticoagulation. Correction of displayed international normalized ratio on two point-of-care test whole-blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent international sensitivity index calibration.
    Poller L; Keown M; Chauhan N; Van Den Besselaar AM; Tripodi A; Shiach C; Jespersen J;
    Br J Haematol; 2003 Sep; 122(6):944-9. PubMed ID: 12956765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Has the Quick or the Owren prothrombin time method the advantage in harmonization for the International Normalized Ratio system?
    Horsti J
    Blood Coagul Fibrinolysis; 2002 Oct; 13(7):641-6. PubMed ID: 12439151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European Concerted Action on Anticoagulation--comparison of fresh plasma and whole blood multicentre ISI calibrations of CoaguChek Mini and TAS PT-NC whole blood prothrombin time point-of-care monitors.
    Poller L; Keown M; Chauhan N; van den Besselaar AM; Tripodi A; Shiach C; Jespersen J;
    Thromb Haemost; 2002 May; 87(5):859-66. PubMed ID: 12038790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
    Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
    Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents.
    Sermon AM; Smith JM; Maclean R; Kitchen S
    Thromb Haemost; 2010 Apr; 103(4):757-65. PubMed ID: 20174759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ISI/INR system in Japan: experience from simultaneous measurement of the same plasma at four different laboratories.
    Uetsuka Y; Sakuragawa N; Wada H; Aizawa Y; Aosaki M
    Semin Thromb Hemost; 2000; 26(1):109-12. PubMed ID: 10805291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simplified method for international normalized ratio (INR) derivation based on the prothrombin time/INR line: an international study.
    Poller L; Ibrahim S; Keown M; Pattison A; Jespersen J
    Clin Chem; 2010 Oct; 56(10):1608-17. PubMed ID: 20798354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Control of oral anticoagulation. Current concepts].
    Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
    Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inter-institute variations in International Normalized Ratio and thrombotest].
    Nozawa T; Hayashi S; Naiki S; Niiya K; Asanoi H; Inoue H
    J Cardiol; 1998 Aug; 32(2):89-94. PubMed ID: 9752617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local verification and assignment of mean normal prothrombin time and International Sensitivity Index values across various instruments: recent experience and outcome from North America.
    Tange JI; Grill D; Koch CD; Ybabez RJ; Krekelberg BJ; Fylling KA; Wiese CR; Baumann NA; Block DR; Karon BS; Chen D; Pruthi RK
    Semin Thromb Hemost; 2014 Feb; 40(1):115-20. PubMed ID: 24381152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to think outside the box? Prothrombin time, international normalised ratio, international sensitivity index, mean normal prothrombin time and measurement of uncertainty: a novel approach to standardisation.
    Favaloro EJ; Hamdam S; McDonald J; McVicker W; Ule V
    Pathology; 2008 Apr; 40(3):277-87. PubMed ID: 18428048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples.
    Lindahl TL; Egberg N; Hillarp A; Ødegaard OR; Edlund B; Svensson J; Sandset PM; Rånby M
    Thromb Haemost; 2004 Jun; 91(6):1223-31. PubMed ID: 15175811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simplified Method for Local Correction of System International Normalized Ratio.
    Chandrashekar V
    Lab Med; 2017 Aug; 48(3):244-248. PubMed ID: 28934513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time].
    Kagawa K; Fukutake K
    Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents.
    Horsti J; Uppa H; Vilpo JA
    Clin Chem; 2005 Mar; 51(3):553-60. PubMed ID: 15665046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
    Loeliger EA; van den Besselaar AM; Lewis SM
    Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.